| Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl) phenothiazine-[1, 2, 3] triazole hybrids D Addla, A Jallapally, D Gurram, P Yogeeswari, D Sriram, S Kantevari Bioorganic & medicinal chemistry letters 24 (1), 233-236, 2014 | 54 | 2014 |
| Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl) phenothiazine-[1, 2, 3] triazole hybrids D Addla, A Jallapally, D Gurram, P Yogeeswari, D Sriram, S Kantevari Bioorganic & medicinal chemistry letters 24 (1), 233-236, 2014 | 54 | 2014 |
| DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages NM de Vasconcelos, G Vliegen, A Gonçalves, E De Hert, R Martín-Pérez, ... Life science alliance 2 (1), 2019 | 51 | 2019 |
| Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents K Gangarapu, S Manda, A Jallapally, S Thota, SS Karki, J Balzarini, ... Medicinal Chemistry Research 23, 1046-1056, 2014 | 43 | 2014 |
| Design, synthesis and evaluation of 1, 2, 3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis D Addla, A Jallapally, D Gurram, P Yogeeswari, D Sriram, S Kantevari Bioorganic & medicinal chemistry letters 24 (8), 1974-1979, 2014 | 35 | 2014 |
| 2-Butyl-4-chloroimidazole based substituted piperazine-thiosemicarbazone hybrids as potent inhibitors of Mycobacterium tuberculosis A Jallapally, D Addla, P Yogeeswari, D Sriram, S Kantevari Bioorganic & Medicinal Chemistry Letters 24 (23), 5520-5524, 2014 | 32 | 2014 |
| Design and green synthesis of 2-(diarylalkyl) aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers PK Kalavagunta, PK Bagul, A Jallapally, S Kantevari, SK Banerjee, ... European Journal of Medicinal Chemistry 83, 344-354, 2014 | 31 | 2014 |
| Design, synthesis and molecular docking of novel structural hybrids of substituted isatin based pyrazoline and thiadiazoline as antitumor agents K Gangarapu, G Thumma, S Manda, A Jallapally, R Jarapula, ... Medicinal Chemistry Research 26, 819-829, 2017 | 25 | 2017 |
| Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5, 11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors D Addla, A Jallapally, A Kanwal, B Sridhar, SK Banerjee, S Kantevari Bioorganic & medicinal chemistry 21 (15), 4485-4493, 2013 | 15 | 2013 |
| Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors A Jallapally, D Addla, P Bagul, B Sridhar, SK Banerjee, S Kantevari Bioorganic & Medicinal Chemistry 23 (13), 3526-3533, 2015 | 11 | 2015 |
| Development of FAP-inhibitors based on squaric acid linked DOTA and DATA5m chelators ES Moon, F Elvas, G Vliegen, E Eppard, L Greifenstein, A Jallapally, ... Nuklearmedizin-NuclearMedicine 59 (02), L18, 2020 | | 2020 |
| Selective Activity-Based Probes Targeting Fibroblast Activation Protein (FAP) J Vrijdag, A Jallapally, AD Decker, K Janssen, F Elvas, S Staelens, ... Proceedings 22 (1), 84, 2019 | | 2019 |
| The Emerging Role of Monocarboxylate Transporter-1 in Cancer: Overview and Therapeutic Opportunities G Thumma, K Gangarapu, A Jallapally, AK Mondru Frontiers in Anti-Cancer Drug Discovery Volume 10 10, 23, 2019 | | 2019 |
| DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages N Van Opdenbosch, A Jallapally, R Geiss-Friedlander, AM Lambeir, ... | | 2019 |
| Development of Antitubercular Agents through Hybridization Strategies, Future Challenges, and Perspectives SK Anvesh Jallapally, Dinesh Kumar, Anjana Devi Tangutur Apple Academic Press, 2016 | | 2016 |
Srinivas KantevariSenior Principal ScientistVerified email at iict.res.in
